Contract Services Methods Development
Toxicology IND Preclinical Research Services by Altogen Labs CRO
Pharmacology and toxicology testing performed both in vitro and in vivo, ensuring safety and effectiveness that is of utmost importance for any novel medic...
July 06, 2021 | News
Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs
Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...
July 01, 2021 | News
Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim
This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesiz...
June 30, 2021 | News
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...
June 23, 2021 | News
Medidata to Offer Secure Platform for Decentralization of Clinical Trials
The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...
June 16, 2021 | News
Novavax Announces Positive Data for COVID-19 Beta (B.1.351) Variant Strain Vaccine
Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine - Primates boosted with rS-B.1.351 vacc...
June 12, 2021 | News
WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates
Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...
June 10, 2021 | News
Elekta's new strategy to focus on growth and access to radiation therapy
At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members from his executive management team introduced the company's mid-term str...
June 08, 2021 | News
WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services
Per the terms of the joint venture agreement, WuXi Biologics and WuXi STA will make capital contributions of USD120 million and USD8...
May 14, 2021 | News
German CDMO Richter-Helm Triples to Accommodate Global Market Demand
“The market for pharmaceutical biotechnology has been continuously growing and further growth is expected. In order to accommodate demand for high va...
May 09, 2021 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
